Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

DXR stock hub

Daxor Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

DXRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

58M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

DXR

In the news

Latest news · DXR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/E5.5

P25 14.9P50 23.2P75 38.5

ROE22.5

P25 -105.6P50 -46.5P75 -3.1

ROIC-2.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All DXR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

198

Groups with data

Currency

USD

Showing 198 of 198 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000027367
Company name	Daxor Corporation
Country	United States
Country code	US
Cusip	239467103
Employees	45
Enterprise value	$58.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Instruments & Supplies
Isin	US2394671034
Last refreshed	2026-05-10
Market cap	$58M
Market cap category	Micro-Cap
Price	$9.95
Price currency	USD
Rev Per Employee	593.07x
Sector	Healthcare
Symbol	DXR
Website	https://www.daxor.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	15.82%
EV Earnings	6.35x
EV Sales Forward	4.85x
EV/Sales	2,182.4x
P/B ratio	1.1x
P/E ratio	5.49x
P/S ratio	2,172.55x
PE Ratio10 Y	35.77x
PE Ratio3 Y	31.49x
PE Ratio5 Y	44.43x
PS Forward	4.82x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	$26,688
Gross Profit Growth	-77.71%
Gross Profit Growth Q	-89.88%
Gross Profit Growth3 Y	-51.34%
Gross Profit Growth5 Y	-36.79%
Net Income	$9.2M
Net Income Growth	1,609.71%
Net Income Growth Q	340.19%
Net Income Growth3 Y	20.98%
Pretax Margin	34,359.17%
Profit Margin	34,359.17%
Profit Per Employee	$203,773
ROA	-1.64
Roa5y	-1.97
ROCE	-2.36
ROE	22.45
Roe5y	14.27
ROIC	-2.36
Roic5y	-3.16

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	2.31%
Cagr15y	0.08%
Cagr1y	33.23%
Cagr20y	-1.15%
Cagr3y	-5.97%
Cagr5y	1.25%
Div CAGR10	0%
EPS Growth	1,567.3
EPS Growth Q	331.1
EPS Growth3 Y	14.52
OCF Growth	2,122.23%
OCF Growth Q	-88.7%
OCF Growth10 Y	-29.39%
Revenue Growth	-77.71x
Revenue Growth Q	-82.61x
Revenue Growth Quarters	1x
Revenue Growth3 Y	-51.34x
Revenue Growth5 Y	-36.79x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0
Assets	$46M
Current Assets	$9,861
Current Liabilities	$122,595
Equity	$45.9M
Interest Coverage	-67.82
Liabilities	$122,595
Long Term Assets	$46M
Long Term Liabilities	$0
Tangible Book Value	$45.9M
Tangible Book Value Per Share	$9.07
WACC	5.86

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.08
Net Working Capital	$-112,734
Working Capital	$-112,734
Working Capital Turnover	$-0.28

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.54%
Dividend per share	$0
Dividend Yield	0%
Last Dividend	$0.03

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	25.7%
1Y total return	33.2%
200-day SMA	11.77
3Y total return	-16.88%
50-day SMA	10.42
50-day SMA vs 200-day SMA	50under200
5Y total return	6.42%
All Time High	30.63
All Time High Change	-67.51%
All Time High Date	2000-03-14
All Time Low	2.13
All Time Low Change	368.24%
All Time Low Date	1990-10-18
ATR	0.77
Beta	0.29
Beta1y	1.1
Beta2y	0.73
Ch YTD	-32.54
High	10.41
High52	14.76
High52 Date	2025-12-29
High52ch	-32.58%
Low	9.75
Low52	7.13
Low52 Date	2025-05-08
Low52ch	39.55%
Ma50ch	-4.51%
Price vs 200-day SMA	-15.43%
RSI	46.81
RSI Monthly	47.75
RSI Weekly	38.89
Sharpe ratio	0.65x
Sortino ratio	1.06
Total Return	-2.54%
Tr YTD	-32.54
Tr15y	1.23%
Tr1m	12.18%
Tr1w	-4.69%
Tr3m	-19.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-1.1M
Operating margin	-4,056.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,957,329%
Float Percent	50.75%
Net Borrowing	-730,221
Shares Insiders	5.43%
Shares Institutions	2.28%
Shares Out	5,827,225
Shares Qo Q	3.02%
Shares Yo Y	2.54%
Short Float	0.11%
Short Ratio	0.25
Short Shares	0.06

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	7,902.75x
Bv Per Share	9.07
Ch10y	24.38
Ch15y	-6.13
Ch1m	12.18
Ch1w	-4.69
Ch1y	33.2
Ch20y	-44.69
Ch3m	-19.4
Ch3y	-16.88
Ch5y	6.42
Ch6m	-23.23
Change	3%
Change From Open	2.05
Close	9.66
Days Gap	0.93
Dollar Volume	216,651.3
Earnings Date	2026-02-27
EBIT	$-1.1M
EPS	$1.81
F Score	2
Financing CF	-570,936
Fiscal Year End	December
Founded	1,970
Graham Number	19.23078
Graham Upside	93.27
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-02-27
Last Report Date	2025-12-31
Last Split Type	Never
Lynch Fair Value	$38.03
Lynch Upside	282.2
Ma150	12.15
Ma150ch	-18.13%
Ma20	10.15
Ma20ch	-1.93%
Next Earnings Date	2026-02-27
Open	9.75
Optionable	No
P OCF Ratio	101.6
Position In Range	30.3
Post Close	9.95
Postmarket Change Percent	3.72
Postmarket Price	$10.32
Price Date	2026-05-08
Ptbv Ratio	1.26
Relative Volume	2.76x
Revenue	26,688x
SBC By Revenue	2,869.85x
Share Based Comp	765,906
Tr20y	-20.64%
Tr6m	-23.23%
Us State	Tennessee
Volume	21,774
Z Score	241.7

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does DXR pay a dividend?

Capital-return profile for this ticker.

Performance

DXR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns DXR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.3%

Float: +50.8% of shares outstanding

Insider ownership

+5.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

DXR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.8

Neutral momentum band

Price vs 200-day MA

-15.4%

50/200-day relationship not available

Beta (5Y)

0.29

Less volatile than the market

Sharpe ratio

0.65

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About DXR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current DXR stock rating?

Daxor Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full DXR analysis?

The full report lives at /stocks/DXR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for DXR?

The latest report frames DXR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the DXR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.